These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19373213)

  • 1. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
    Egan BM; Basile JN; Rehman SU; Davis PB; Grob CH; Riehle JF; Walters CA; Lackland DT; Merali C; Sealey JE; Laragh JH
    Am J Hypertens; 2009 Jul; 22(7):792-801. PubMed ID: 19373213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
    Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor responses to antihypertensive drug types.
    Alderman MH; Cohen HW; Sealey JE; Laragh JH
    Am J Hypertens; 2010 Sep; 23(9):1031-7. PubMed ID: 20725055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
    Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
    Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension].
    Olmer M; Ducros J; Grandvuillemin M; Salvadori JM
    Sem Hop; 1977 May; 53(20):1147-53. PubMed ID: 20666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
    Nussberger J; Gradman AH; Schmieder RE; Lins RL; Chiang Y; Prescott MF
    Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H
    Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
    Bühler FR; Lütold BE
    Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ; Laragh JH; Atlas SA; Case DB
    J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF; Laragh JH
    Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA; Lopez-Ovejero JA; Drayer JI; Case DB; Laragh JH
    Arch Intern Med; 1977 Mar; 137(3):284-9. PubMed ID: 843146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.